Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
981 Methylation of the hTERT promoter: a novel cancer biomarker for leptomeningeal metastasis detection in cerebrospinal fluids Clinical Cancer Research, March 5, 2013
982 CD44 and OTP are strong prognostic markers for pulmonary carcinoids Clinical Cancer Research, March 5, 2013
983 MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia Clinical Cancer Research, March 5, 2013 Clinical Article
984 Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: A Cooperative Group Correlative Study Clinical Cancer Research, March 5, 2013
985 Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer Cancer Cell, March 5, 2013 Clinical Article
986 Role of Brutons tyrosine kinase (BTK) in myeloma cell migration and induction of bone disease American Journal of Hematology, March 5, 2013 Clinical Article
987 A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non-Small Cell Lung Cancer Patients Clinical Cancer Research, March 5, 2013 Clinical Article
988 Functional Analysis of Genes in Regions Commonly Amplified in High-Grade Serous and Endometrioid Ovarian Cancer Clinical Cancer Research, March 5, 2013 Clinical Article
989 Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas Full Text Haematologica, March 5, 2013 Clinical Article
990 Low Expression of CyclinH and Cyclin-Dependent Kinase 7 Can Decrease the Proliferation of Human Esophageal Squamous Cell Carcinoma Digestive Diseases and Sciences, March 5, 2013 Clinical Article
991 A new cell culture-based assay quantifies VKORC1 function and reveals warfarin resistance phenotypes not shown by the DTT-driven VKOR assay Journal of Thrombosis and Haemostasis, March 5, 2013 Clinical Article
992 Myocyte enhancer factor 2C in hematopoiesis and leukemia Oncogene, March 5, 2013 Review Article Clinical Article
993 ATM kinase activity modulates ITCH E3-ubiquitin ligase activity Oncogene, March 5, 2013 Clinical Article
994 Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma Full Text World Journal of Gastroenterology, March 5, 2013 Clinical Article
995 Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations Molecular Cancer Research, March 5, 2013 Clinical Article
996 Glutathione S-transferase P1 Ile105Val polymorphism contributes to increased risk of gastric cancer in East Asians Tumor Biology, March 5, 2013 Evidence Based Medicine Clinical Article
997 KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer Journal of Cancer Research & Clinical Oncology, March 5, 2013 Clinical Article
998 Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65 Full Text Journal of Biomedical Science, March 5, 2013
999 Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia Hematology, March 5, 2013
1000 The significance of MUM1/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases Leukemia Research, March 5, 2013 Clinical Article
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryAs reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryAs reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summary1 Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Mayo Clinic Proceedings, April 2, 2013 Clinical Guideline
2 Intrinsic Resistance to JAK2 Inhibition in Myelofibrosis Clinical Cancer Research, April 1, 2013
3 Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer New England Journal of Medicine, April 2, 2013
4 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions Cochrane Reviews, April 1, 2013 Review Article
5 Leukaemia update. Part 1: diagnosis and management British Medical Journal, April 9, 2013 Review Article
6 Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma Neuro-Oncology, March 26, 2013
7 P21-activated kinase 1 (pak1) as a therapeutic target in braf wild-type melanoma Journal of the National Cancer Institute, April 1, 2013
8 A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis Annals of Oncology, April 1, 2013
9 Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Mayo Clinic Proceedings, April 9, 2013 Free full text Clinical Guideline
10 Cancer Immunotherapy: Present Status, Future Perspective, and a New Paradigm of Peptide Immunotherapeutics Discovery Medicine, April 1, 2013 Free full text Review Article
11 Aberrant BAF57 Signaling Facilitates Pro-metastatic Phenotypes Clinical Cancer Research, April 1, 2013
12 Serum levels of IL-6 and IL-1beta can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer British Journal of Cancer, April 24, 2013
13 CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy BMC Cancer, April 3, 2013 Free full text
14 Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging and lung metastases in patients with breast cancer Cancer Prevention Research, April 3, 2013
15 MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia Leukemia, April 1, 2013
16 Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas Lung Cancer, April 12, 2013
17 Tumor-suppressive microRNA-145 targets catenin δ-1 to regulate Wnt/β-catenin signaling in human colon cancer cells Cancer Letters, April 2, 2013
18 Association of interleukin-10, tumor necrosis factor-alpha and transforming growth factor-beta gene polymorphisms with the outcome of diffuse large B-cell lymphomas International Journal of Clinical Oncology, March 29, 2013
19 Amiodarone and the risk of cancer Cancer, April 9, 2013
20 Expression of CD133 in acute leukemia Medical Oncology, April 2, 2013
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close